A Second-generation AI Based Therapeutic Regimen in Patients With Gaucher Disease Treated With Enzyme Replacement Therapy.

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

March 1, 2023

Study Completion Date

March 1, 2023

Conditions
Gaucher Disease Type 1
Interventions
COMBINATION_PRODUCT

Enzyme replacement therapy for Gaucher disease in combination with altus care application

In coordination with the patient's treating physician and the home treating nurse, an individualized treatment plan was prepared for each patient within a pre-defined range of minimal and maximal once in two weeks enzyme replacement therapy dosages and timing frames for its administration. Per protocol, the patient's monthly dose was not changed, but each dose and the timing of administration was changed randomly using the app.

Trial Locations (1)

96955

Hebrew university, Jerusalem

All Listed Sponsors
lead

Hadassah Medical Organization

OTHER